SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-031629
Filing Date
2011-03-31
Accepted
2011-03-31 17:28:25
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c14674e10vk.htm 10-K 1573522
2 EXHIBIT 3.2 c14674exv3w2.htm EX-3.2 105910
3 EXHIBIT 10.13 c14674exv10w13.htm EX-10.13 73447
4 EXHIBIT 10.14 c14674exv10w14.htm EX-10.14 117572
5 EXHIBIT 21 c14674exv21.htm EX-21 707
6 EXHIBIT 23.1 c14674exv23w1.htm EX-23.1 1883
7 EXHIBIT 31.1 c14674exv31w1.htm EX-31.1 9025
8 EXHIBIT 31.2 c14674exv31w2.htm EX-31.2 9243
9 EXHIBIT 32.1 c14674exv32w1.htm EX-32.1 3270
10 EXHIBIT 32.2 c14674exv32w2.htm EX-32.2 3557
  Complete submission text file 0000950123-11-031629.txt   1899272
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 11727751
SIC: 2834 Pharmaceutical Preparations